Table 1.

Recipient demographics (n = 108).

Variable	Auto-antibody positive (n = 72)	Auto-antibody negative (n = 36)	p
Age, years	49.1 ± 15.1	48.4 ± 14.8	0.82
Male gender, n (%)	44 (61%)	16 (44%)	0.10
Diagnosis, n (%)			0.72
COPD or α1-AE	23 (32%)	11 (31%)
Cystic fibrosis	15 (21%)	9 (25%)
Pulmonary fibrosis	19 (26%)	10 (28%)
Pulmonary hypertension	3 (4%)	0 (0%)
Re-transplant	5 (7%)	1 (3%)
Other diagnosis	7 (10%)	5 (14%)
Bilateral lung transplant, n (%)	70 (97%)	33 (92%)	0.34
Cardiopulmonary bypass, n (%)	31 (43%)	16 (44%)	0.94
Ischemic time, mean ± SD	304 ± 52	295 ± 76	0.65
CMV mismatch (R-/D+), n (%)	17 (24%)	13 (36%)	0.17
Allosensitized at transplant, n (%)	30 (42%)	10 (28%)	0.16
HLA mismatch, median	5	5	0.45
Primary graft dysfunction at T0			0.23
PGD grade 0	16 (22%)	12 (33%)
PGD grade 1	19 (26%)	13 (36%)
PGD grade 2	21 (29%)	6 (17%)
PGD grade 3	16 (22%)	5 (14%)
Post-transplant ventilator days, median	2	1	.52